+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Physiological degradation of Abeta in the brain



Physiological degradation of Abeta in the brain



Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 8: 48-53




(PDF emailed within 1 workday: $29.90)

Accession: 055001634

Download citation: RISBibTeXText

PMID: 22787752


Related references

Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance. Journal of Biological Chemistry 285(29): 22091-22102, 2010

Calpain inhibitor MDL28170 modulates Abeta formation by inhibiting the formation of intermediate Abeta subscript 46 and protecting Abeta from degradation. FASEB journal: official ication of the Federation of American Societies for Experimental Biology 20(2): 331-333, 2006

Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition. Journal of Neuroscience 27(32): 8628-8635, 2007

Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Molecular and Cellular Neurosciences 15(2): 183-198, 2000

Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta. Journal of Biological Chemistry 283(28): 19489-19498, 2008

GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. Current Alzheimer Research 6(2): 118-131, 2009

Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta. Journal of Neuroscience 29(36): 11393-8, 2009

Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation. Molecular Neurodegeneration 3(): 22-22, 2009

Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. Embo Reports 1(6): 530-535, 2001

Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP. Plos One 1(): E51-E51, 2006

MISSENSE MUTATIONS IN INSULIN - DEGRADING ENZYME ASSOCIATED WITH A DIABETIC PHENOTYPE IN RATS DECREASE Abeta DEGRADATION IN BRAIN. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 19 8, 2002

Calpain inhibitor MDL28170 modulates Abeta formation by inhibiting the formation of intermediate Abeta46 and protecting Abeta from degradation. Faseb Journal 20(2): 331-333, 2005

Abeta immunization in aged vervet monkeys reduces Abeta levels in brain and CSF. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 133 5, 2003

The F(ab)'2 fragment of an Abeta-specific monoclonal antibody reduces Abeta deposits in the brain. Neurobiology of Disease 20(2): 541-549, 2005

The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. Journal of Neuroscience 23(26): 8867-8871, 2003